Revision liver transplant for persistent infection and localized aspergillosis after hepatic artery thrombosis

Experimental and Clinical Transplantation

Volumn 12, Issue 4, 2014, Pages 381-383

  Jafarian, Ali ^a   Kasraianfard, Amir ^a   Nassiri Toosi, Mohssen ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; Aspergillus; Complications; Sepsis

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; CYCLOSPORIN; GANCICLOVIR; IMIPENEM; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN; PREDNISOLONE; RECOMBINANT PLASMINOGEN ACTIVATOR; TACROLIMUS; TAZOBACTAM; THYMOCYTE ANTIBODY; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACUTE GRAFT REJECTION; ADULT; ANASTOMOSIS; ARTERY DISSECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLEDOCHOJEJUNOSTOMY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; END STAGE LIVER DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HEPATIC ARTERY THROMBOSIS; HEPATOJEJUNOSTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PERIOD; THROMBECTOMY; TREATMENT FAILURE; ACINETOBACTER INFECTIONS; ADVERSE EFFECTS; ARTERIAL OCCLUSIVE DISEASES; ASPERGILLOSIS; HEPATIC ARTERY; ISOLATION AND PURIFICATION; LIVER ABSCESS; MICROBIOLOGY; PATHOPHYSIOLOGY; REOPERATION; SEPSIS; STENOSIS, OCCLUSION AND OBSTRUCTION; THROMBOSIS; TIME; TREATMENT OUTCOME; VASCULAR PATENCY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ARTERIAL OCCLUSIVE DISEASES; ASPERGILLOSIS; CONSTRICTION, PATHOLOGIC; HEPATIC ARTERY; HUMANS; LIVER ABSCESS; LIVER TRANSPLANTATION; MALE; REOPERATION; SEPSIS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84904990151     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2013.0129     Document Type: Article

References (15)

1. Stange BJ, Glanemann M, Nuessler NC, Settmacher U, Steinmüller T, Neuhaus P. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2003;9(6):612-620.
2. Rosenhagen M, Feldhues R, Schmidt J, Hoppe-Tichy T, Geiss HK. A risk profile for invasive aspergillosis in liver transplant recipients. Infection. 2009;37(4):313-319.
3. Silva MA, Jambulingam PS, Gunson BK, et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl. 2006;12(1):146-151.
4. Drazan K, Shaked A, Olthoff KM, et al. Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT). Am Surg. 1996;62(3):237-240.
5. Hesselink EJ, Klompmaker IJ, Grond J, Gouw AS, van Schilfgaarde R, Sloof MJ. Hepatic artery thrombosis (HAT) after orthotopic transplantation (OLT) - the influence of technical factors and rejection episodes. Transplant Proc. 1989;21(1 Pt 2):2468.
6. Warnaar N, Polak WG, de Jong KP, et al. Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation. Liver Transpl. 2010;16(7):847-855.
7. Eghtesad B, Kadry Z, Fung J. Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice). Liver Transpl. 2005;11(8):861-871.
8. Chen GH, Fu BS, Yang Y, et al. Early liver retransplantation versus late liver retransplantation: analysis of a single-center experience. Chin Med J (Engl). 2008;121(20):1992-1996.
9. Alqahtani SA, Larson AM. Adult liver transplantation in the USA. Curr Opin Gastroenterol. 2011;27(3):240-247.
10. Shi SH, Lu AW, Shen Y, et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J (Engl). 2008;121(7):625-630.
11. Osawa M, Ito Y, Hirai T, et al. Risk factors for invasive aspergillosis in living donor liver transplant recipients. Liver Transpl. 2007;13(4):566-570.
12. Fung JJ. Fungal infection in liver transplantation. Transpl Infect Dis. 2002;4 (Suppl 3):18-23.
13. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44-69.
14. Kusne S, Torre-Cisneros J, Mañez R, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis. 1992;166(6):1379-1383.
15. Nikeghbalian S, Salahi R, Salahi H, et al. Hepatic abscesses after liver transplant: 1997-2008. Exp Clin Transplant. 2009;7(4):256-260.